{"id":105,"date":"2019-09-22T17:52:16","date_gmt":"2019-09-22T17:52:16","guid":{"rendered":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/chapter\/3-9-sulfonamides\/"},"modified":"2025-01-16T22:25:08","modified_gmt":"2025-01-16T22:25:08","slug":"3-9-sulfonamides","status":"publish","type":"chapter","link":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/chapter\/3-9-sulfonamides\/","title":{"raw":"3.9 Sulfonamides","rendered":"3.9 Sulfonamides"},"content":{"raw":"Sulfonamides are one of the oldest broad-spectrum antimicrobial agents and work by competitively inhibiting bacterial metabolic enzymes needed for bacterial function.\n\nMechanism of Action:<\/strong> This mechanism of action provides bacteriostatic inhibition of growth against a wide spectrum of gram-positive and gram-negative pathogens.\n\nIndications:<\/strong> Sulfonamides are used to treat urinary tract infections, otitis media, acute exacerbations of chronic bronchitis, and diarrhea that can occur when travelling outside one's country.\n\nNursing Considerations:<\/strong> Allergic reactions to sulfonamide medications are common and, therefore, clients should be monitored carefully for adverse effects, including delayed hypersensitivity reactions. Sulfonamide medications increase the risk of crystalluria that can cause kidney stones or decreased kidney function; therefore, clients should increase their water intake while taking these medications.[footnote]This work is a derivative of Microbiology<\/a> by OpenStax<\/a> licensed under CC BY 4.0<\/a>. Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a>[\/footnote]<\/sup>\n\nSide Effects\/Adverse Effects: <\/strong>Common side effects include GI upset such as nausea, vomiting, and diarrhea. Other side effects may include headache and photosensitivity. Sulfonamides should be discontinued at the first appearance of skin rash.\n\nHealth Teaching & Health Promotion: <\/strong>The client should be taught to complete the full prescribed dose of medications and take measures to not skip doses. If a dose is missed, the client should take the missed dose as soon as possible unless it is near the next dosing time. The medication can cause increased photosensitivity, and clients should be educated to use sunscreen and protective clothing with sun exposure. The client should also report any rash, sore throat, fever, or mouth sores that might occur. Unusual bleeding or bruising should also be reported to the provider. If clients are receiving prolonged therapy, they may require platelet count monitoring.[footnote]uCentral from Unbound Medicine. https:\/\/www.unboundmedicine.com\/ucentral<\/a>[\/footnote]<\/sup>\n\nNow let's take a closer look at the medication grid for trimethoprim-sulfamethoxazole in Table 3.9.[footnote]This work is a derivative of DailyMed<\/a>\u00a0by\u00a0U.S. National Library of Medicine<\/a> in the\u00a0Public Domain<\/a>. [\/footnote]\u00a0<\/sup>\n\nTable 3.9 Sulfonamides Medication Grid\n\n\n\n\n
\n
Class\/Subclass<\/strong><\/h5>\n<\/th>\n
\n
Prototype\/Generic<\/strong><\/h5>\n<\/th>\n
\n
Nursing Considerations<\/strong><\/h5>\n<\/th>\n
\n
Therapeutic Effects<\/strong><\/h5>\n<\/th>\n
\n
Side\/Adverse Effects<\/strong><\/h5>\n<\/th>\n<\/tr>\n
Sulfonamides<\/th>\ntrimethoprim \u2013 sulfamethoxazole<\/a><\/td>\nCheck for allergies\n\nAnticipate dose adjustment for renal impairment\n\nAdminister PO with 8 oz. of water\n\nMonitor urine output and for cloudiness or crystals\n\nDo not administer IM\n\nUse cautiously with cardiac antidysrhythmics\n\nUse cautiously with oral antidiabetics; may increase hypoglycemic effects. Monitor glucose level carefully\n\nUse cautiously with anticoagulant medications such as warfarin; may increase risk of bleeding.\n\nMonitor INR and for signs of bleeding<\/td>\nMonitor for systemic signs\u00a0of infection:\n\n-WBCs\n\n-Fever\n\nMonitor actual site of infection\n\nMonitor culture results, if obtained<\/td>\nGI upset, including nausea, vomiting, and diarrhea\n\nHeadache\n\nPhotosensitivity or increased intolerance to sunlight\n\nSAFETY: Sulfonamides, including sulfonamide-containing products such as sulfamethoxaole\/trimethoprim, should be discontinued at the first appearance of skin rash of any sign of adverse reaction<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n \n
\n

Critical Thinking Activity 3.9\"Image<\/h2>\n<\/header>\n
\n\nUsing the above grid information, consider the following clinical scenario question:<\/strong>\n\nA nurse is caring for an elderly client with diabetes who has been prescribed trimethoprim-sulfamethoxazole for a urinary tract infection. What nursing interventions will be implemented prior to medication administration?\n\nNote: Answers to the Critical Thinking activities can be found in the \u201cAnswer Key<\/a>\u201d section at the end of the book.\n\n<\/div>\n<\/div>","rendered":"

Sulfonamides are one of the oldest broad-spectrum antimicrobial agents and work by competitively inhibiting bacterial metabolic enzymes needed for bacterial function.<\/p>\n

Mechanism of Action:<\/strong> This mechanism of action provides bacteriostatic inhibition of growth against a wide spectrum of gram-positive and gram-negative pathogens.<\/p>\n

Indications:<\/strong> Sulfonamides are used to treat urinary tract infections, otitis media, acute exacerbations of chronic bronchitis, and diarrhea that can occur when travelling outside one’s country.<\/p>\n

Nursing Considerations:<\/strong> Allergic reactions to sulfonamide medications are common and, therefore, clients should be monitored carefully for adverse effects, including delayed hypersensitivity reactions. Sulfonamide medications increase the risk of crystalluria that can cause kidney stones or decreased kidney function; therefore, clients should increase their water intake while taking these medications.[1]<\/sup><\/a><\/sup><\/p>\n

Side Effects\/Adverse Effects: <\/strong>Common side effects include GI upset such as nausea, vomiting, and diarrhea. Other side effects may include headache and photosensitivity. Sulfonamides should be discontinued at the first appearance of skin rash.<\/p>\n

Health Teaching & Health Promotion: <\/strong>The client should be taught to complete the full prescribed dose of medications and take measures to not skip doses. If a dose is missed, the client should take the missed dose as soon as possible unless it is near the next dosing time. The medication can cause increased photosensitivity, and clients should be educated to use sunscreen and protective clothing with sun exposure. The client should also report any rash, sore throat, fever, or mouth sores that might occur. Unusual bleeding or bruising should also be reported to the provider. If clients are receiving prolonged therapy, they may require platelet count monitoring.[2]<\/sup><\/a><\/sup><\/p>\n

Now let’s take a closer look at the medication grid for trimethoprim-sulfamethoxazole in Table 3.9.[3]<\/sup><\/a>\u00a0<\/sup><\/p>\n

Table 3.9 Sulfonamides Medication Grid<\/p>\n\n\n\n\n
\n
Class\/Subclass<\/strong><\/h5>\n<\/th>\n
\n
Prototype\/Generic<\/strong><\/h5>\n<\/th>\n
\n
Nursing Considerations<\/strong><\/h5>\n<\/th>\n
\n
Therapeutic Effects<\/strong><\/h5>\n<\/th>\n
\n
Side\/Adverse Effects<\/strong><\/h5>\n<\/th>\n<\/tr>\n
Sulfonamides<\/th>\ntrimethoprim \u2013 sulfamethoxazole<\/a><\/td>\nCheck for allergies<\/p>\n

Anticipate dose adjustment for renal impairment<\/p>\n

Administer PO with 8 oz. of water<\/p>\n

Monitor urine output and for cloudiness or crystals<\/p>\n

Do not administer IM<\/p>\n

Use cautiously with cardiac antidysrhythmics<\/p>\n

Use cautiously with oral antidiabetics; may increase hypoglycemic effects. Monitor glucose level carefully<\/p>\n

Use cautiously with anticoagulant medications such as warfarin; may increase risk of bleeding.<\/p>\n

Monitor INR and for signs of bleeding<\/td>\n

Monitor for systemic signs\u00a0of infection:<\/p>\n

-WBCs<\/p>\n

-Fever<\/p>\n

Monitor actual site of infection<\/p>\n

Monitor culture results, if obtained<\/td>\n

GI upset, including nausea, vomiting, and diarrhea<\/p>\n

Headache<\/p>\n

Photosensitivity or increased intolerance to sunlight<\/p>\n

SAFETY: Sulfonamides, including sulfonamide-containing products such as sulfamethoxaole\/trimethoprim, should be discontinued at the first appearance of skin rash of any sign of adverse reaction<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

\n
\n

Critical Thinking Activity 3.9\"Image<\/h2>\n<\/header>\n
\n

Using the above grid information, consider the following clinical scenario question:<\/strong><\/p>\n

A nurse is caring for an elderly client with diabetes who has been prescribed trimethoprim-sulfamethoxazole for a urinary tract infection. What nursing interventions will be implemented prior to medication administration?<\/p>\n

Note: Answers to the Critical Thinking activities can be found in the \u201cAnswer Key<\/a>\u201d section at the end of the book.<\/p>\n<\/div>\n<\/div>\n

  1. This work is a derivative of Microbiology<\/a> by OpenStax<\/a> licensed under CC BY 4.0<\/a>. Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a> ↵<\/a><\/li>
  2. uCentral from Unbound Medicine. https:\/\/www.unboundmedicine.com\/ucentral<\/a> ↵<\/a><\/li>
  3. This work is a derivative of DailyMed<\/a>\u00a0by\u00a0U.S. National Library of Medicine<\/a> in the\u00a0Public Domain<\/a>. ↵<\/a><\/li><\/ol><\/div>","protected":false},"author":83,"menu_order":8,"template":"","meta":{"pb_show_title":"on","pb_short_title":"","pb_subtitle":"","pb_authors":[],"pb_section_license":""},"chapter-type":[48],"contributor":[],"license":[],"class_list":["post-105","chapter","type-chapter","status-publish","hentry","chapter-type-numberless"],"part":82,"_links":{"self":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/105","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters"}],"about":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/types\/chapter"}],"author":[{"embeddable":true,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/users\/83"}],"version-history":[{"count":1,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/105\/revisions"}],"predecessor-version":[{"id":106,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/105\/revisions\/106"}],"part":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/parts\/82"}],"metadata":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/105\/metadata\/"}],"wp:attachment":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/media?parent=105"}],"wp:term":[{"taxonomy":"chapter-type","embeddable":true,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapter-type?post=105"},{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/contributor?post=105"},{"taxonomy":"license","embeddable":true,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/license?post=105"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}